# ZYCUBO
> **NDA211241** · New Drug Application · Sponsor: SENTYNL THERAPS INC · Approved 2026-01-12
## Drug
- **FDA Application Number:** NDA211241
- **Application type:** New Drug Application
- **Brand name:** ZYCUBO
- **Generic name:** COPPER HISTIDINATE
- **Active ingredients:** COPPER HISTIDINATE
- **Dosage form:** POWDER
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** SENTYNL THERAPS INC
- **Manufacturer:** Sentynl Therapeutics, Inc.
- **First approval:** 2026-01-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211241)
---
*AI Analytics · CC0 1.0*